Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, December 8, 2024
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550
Life Sciences Times
-
December 2, 2024
Pharma
Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B
Life Sciences Times
-
November 15, 2024
Pharma
Aptar Pharma Enters into Exclusive Agreement with Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
Life Sciences Times
-
November 7, 2024
Pharma
Scripps Research Advances Breakthrough Regenerative Medicines to Reverse Aging-Related Diseases
Life Sciences Times
-
October 30, 2024
Pharma
Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint
Life Sciences Times
-
October 30, 2024
Pharma
Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
Life Sciences Times
-
October 15, 2024
0
Pharma
PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
Life Sciences Times
-
September 27, 2024
0
Pharma
Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America
Life Sciences Times
-
September 26, 2024
0
Pharma
Aptar Pharma Enters into Exclusive Agreement with Pulmotree to Develop and Promote Kolibri™ Non-Propellant Liquid Inhaler Platform
Life Sciences Times
-
September 10, 2024
0
Pharma
ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics
Life Sciences Times
-
September 10, 2024
0
Pharma
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan)
Life Sciences Times
-
September 6, 2024
0
Pharma
Vetter’s European Clinical Site Successfully Completes First 100 Aseptic Fills
Life Sciences Times
-
September 5, 2024
0
Pharma
IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer’s Disease
Life Sciences Times
-
September 4, 2024
0
Pharma
Transforming the Future of Medicine with RNA-Based Therapies
Life Sciences Times
-
August 27, 2024
0
Pharma
Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor
Life Sciences Times
-
August 26, 2024
0
Pharma
Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults
Life Sciences Times
-
August 12, 2024
0
Pharma
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate
Life Sciences Times
-
August 12, 2024
0
1
2
3
...
59
Page 1 of 59
Most Read
Cleveland Museum of Natural History Solidifies Sustainability Commitment with Highest U.S. Green Building Achievement
December 5, 2024
Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock
December 5, 2024
IMPLANET Announces Financing of Around €2 Million
December 5, 2024
Charles River Introduces Global Biotech Incubator Program
December 5, 2024